# Protegrin-1: Porcine Cathelicidin β-Hairpin Antimicrobial Peptide — Membrane Pharmacology Research Profile
> Research Use Only (RUO). Protegrin-1 is discussed here strictly as a laboratory research reagent — an antimicrobial / host-defense peptide and membrane-active model peptide — for in vitro and preclinical studies. Nothing below is medical, veterinary, therapeutic, or dosing guidance, and none of it describes human or animal use outside controlled research settings. Protegrin-1 is membrane-disruptive and hemolytic at higher concentrations and must be handled only under appropriate laboratory safety controls.
Protegrin-1 (PG-1) is an 18-residue, cationic, β-hairpin antimicrobial peptide derived from the porcine cathelicidin family and one of the most extensively studied membrane-active host-defense peptides. Constrained by two disulfide bonds into a rigid β-hairpin and rich in arginine, it permeabilizes microbial membranes with potent, broad-spectrum activity — making it a benchmark reagent for antimicrobial-peptide biophysics, antibacterial screening, and selectivity-engineering research. This profile summarizes its molecular identity, membrane mechanism, experimental applications, and handling considerations, with every claim tied to a verifiable primary-literature citation.
For the broader peptide class protegrin-1 belongs to, see the Peptides.SO antimicrobial peptides classification guide and the cathelicidin sibling LL-37 profile.
Host-Defense-Peptide Context
Cathelicidins are a major family of host-defense peptides; in pigs the family includes the protegrins, of which PG-1 is the archetype. Like the human cathelicidin LL-37, protegrin-1 is studied as a template for understanding how cationic host-defense peptides achieve broad-spectrum activity, and its transcriptional regulation has been mapped to clarify how expression is controlled in host tissues (Gene, 2024). Where the bee-venom peptide melittin is the canonical non-host membrane-lytic model, protegrin-1 is the canonical host-defense β-hairpin — and the two are frequently compared as membrane-active reference peptides. For that contrast, see the melittin membrane-pharmacology profile.
Molecular Identity
Protegrin-1 is a linear 18-amino-acid peptide folded into a two-stranded antiparallel β-hairpin stabilized by two disulfide bonds (Cys-Cys pairings that lock the hairpin). Its surface is strongly cationic — arginine residues dominate the charge — and amphipathic, segregating hydrophobic and charged regions across the hairpin. This rigid, cationic architecture is the structural basis for its membrane activity, and recent work on local structural constraints and charge distribution in protegrin-1 dissects how these features govern function (Drug Resist Updat, 2026). Because defined material is essential for reproducible biophysics, recombinant strategies such as dual expression plasmids for protegrin-1 have been developed for scalable production (MethodsX, 2026).
Membrane Mechanism: Permeabilization and Pore Formation
The central pharmacological fact of protegrin-1 biology is direct microbial-membrane permeabilization. Rather than acting on a single receptor, PG-1 partitions into anionic bacterial membranes, where its cationic β-hairpin disrupts bilayer packing and, above a threshold concentration, forms transmembrane pores that compromise membrane integrity and kill the cell. This mechanism gives potent, broad-spectrum, and rapid bactericidal activity, including against multidrug-resistant organisms — for example multidrug-resistant porcine ExPEC (Vet Sci, 2025) and the difficult Gram-negative pathogen Acinetobacter baumannii, reviewed for PG-1 and its analogues (Pharmaceuticals (Basel), 2025).
Because its membrane action is charge-driven and non-selective at higher concentrations, PG-1 also disrupts mammalian membranes (hemolysis) — the central liability that drives selectivity-engineering research. For laboratory work, this means protegrin-1 is most informative as a concentration-dependent membrane-permeabilizing probe, where the therapeutic-window analog (selectivity index) is the key engineered property.
Signaling and Experimental Readouts
Because protegrin-1 acts at the membrane rather than through a classical signaling receptor, its research readouts center on antimicrobial potency, membrane permeabilization, selectivity, and downstream consequences. Commonly studied contexts include:
- •Antibacterial screening: PG-1 is a standard potent positive control and template against resistant pathogens (Vet Sci, 2025; Pharmaceuticals (Basel), 2025).
- •Selectivity engineering: because unmodified PG-1 is hemolytic, much research focuses on taming it — designing PG-1 analogs with improved antibacterial selectivity (Pharmaceutics, 2023) and novel PG-1-based AMPs evaluated in silico and in vitro (Microb Pathog, 2024).
- •High-throughput sequence–activity mapping: PG-1 has served as a scaffold for deep mutational scanning combined with machine learning to chart antimicrobial sequence space (Nat Biomed Eng, 2024).
- •Functional repurposing: beyond antibacterials, PG-1 has been repurposed as a dual-function amyloid inhibitor (ACS Chem Neurosci, 2023), and the related protegrin-2 examined as a SARS-CoV-2 main-protease inhibitor (Comput Struct Biotechnol J, 2023).
These citations describe laboratory and preclinical research models and are included to map the research breadth of protegrin-1; they do not constitute therapeutic claims. Protegrin-1 remains, in this profile, a reagent for controlled investigation only.
Protegrin-1 Among Antimicrobial and Membrane-Active Peptides
Protegrin-1 is best interpreted alongside related host-defense and membrane-active peptide classes. As a β-hairpin cathelicidin it sits with the broader AMP family and is the porcine counterpart to the human cathelicidin LL-37; mechanistically it overlaps with all cationic membrane-permeabilizing peptides. Researchers routinely benchmark PG-1 against these classes:
- •within the broader antimicrobial-peptide family — see the AMP classification and mechanisms guide;
- •versus the human cathelicidin — see the LL-37 profile;
- •versus the non-host membrane-lytic model — the bee-venom melittin profile;
- •versus membrane-translocating cell-penetrating peptides — see the CPP mechanisms guide.
This comparative framing clarifies which features of PG-1's action are β-hairpin/host-defense-specific versus shared across cationic membrane peptides.
Handling and Assay Considerations for Researchers
- •Safety first: Protegrin-1 is membrane-disruptive and hemolytic at higher concentrations — handle with appropriate PPE and institutional biosafety controls.
- •Reconstitution: Handle PG-1 as a small, cationic, disulfide-bonded research peptide — see the peptide reconstitution guide and solubility and solvent selection guide. Preserve disulfide pairing; avoid reducing conditions that would unfold the β-hairpin.
- •Purity and identity: Confirm sequence, disulfide pairing, and purity by HPLC and mass spectrometry — review purity testing methods and how to read a certificate of analysis.
- •Assay design: Treat PG-1 as a concentration-dependent membrane probe; pair antimicrobial MIC assays with hemolysis/cytotoxicity to compute a selectivity index, control membrane/lipid composition, and include reference AMPs. For research-grade sourcing, use the how to evaluate peptide suppliers guide.
Frequently Asked Research Questions
What is protegrin-1's mechanism?
PG-1 is a membrane-active antimicrobial peptide: its cationic β-hairpin partitions into anionic microbial membranes and forms pores that permeabilize and kill the cell — it does not act through a classical signaling receptor (Drug Resist Updat, 2026).
Why is it so widely used in research?
Its potent, rapid, broad-spectrum membrane disruption — including against multidrug-resistant pathogens — makes it a benchmark template for AMP biophysics and antibacterial design (Pharmaceuticals (Basel), 2025).
How do researchers make it selective?
Through analog design that reduces hemolysis while preserving antibacterial potency, often guided by deep mutational scanning and structure–activity mapping (Pharmaceutics, 2023; Nat Biomed Eng, 2024).
What research models employ protegrin-1?
Resistant-pathogen antibacterial assays, membrane-biophysics systems, selectivity-engineering screens, and repurposing studies such as amyloid inhibition (Vet Sci, 2025; ACS Chem Neurosci, 2023).
Summary
Protegrin-1 is an 18-residue cationic, disulfide-locked β-hairpin antimicrobial peptide from the porcine cathelicidin family, whose defining action is direct, concentration-dependent microbial-membrane permeabilization and pore formation rather than receptor signaling. Its potent, broad-spectrum, rapid activity — including against multidrug-resistant organisms — makes it a foundational laboratory reagent for antimicrobial-peptide biophysics, antibacterial screening, and selectivity-engineering research, best studied with defined material, intact disulfides, and paired antimicrobial/hemolysis assays to quantify the selectivity index. As the porcine counterpart to the human cathelicidin LL-37 and a benchmark β-hairpin, it is most informative when compared against the wider AMP and membrane-active peptide classes. As with all compounds profiled on Peptides.SO, protegrin-1 is presented for research use only, with no human, veterinary, therapeutic, or dosing application implied.
---
This article is provided for informational and research purposes only. Protegrin-1 is a research reagent intended for laboratory use only and is not approved for human or veterinary use in this context. It is membrane-disruptive and hemolytic; always follow institutional safety and compliance requirements.